Procter & Gamble Co, The (P&G) in Consumer Health

May 2023

Procter & Gamble has maintained its position in 2022. Growth has been driven by persistent consumer loyalty to well-known brands such as Vicks, Metamucil, Align and Neurobion. While North America is a key region, Western Europe and Latin America have provided significant gains. Considering ongoing growth within vitamins and dietary supplements, Procter & Gamble would be wise to diversify its sales in high-growth economies as well as expand and diversify its VDS portfolio.

USD 570
Request More Information


Files are delivered directly into your account soon after payment is received and any tax certification is verified (where applicable).

This report comes in PPT.


Euromonitor International's report on Procter & Gamble Co, The delivers a detailed strategic analysis of the company's business, examining its performance in the Consumer Health market and the global economy. Company and market share data provide a detailed look at the financial position of Procter & Gamble Co, The, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of Procter & Gamble Co, The.

This report examines:

  • Company share by region and sector
  • Brand portfolio
  • New product developments
  • Marketing and distribution strategies

A detailed SWPT analysis of Procter & Gamble Co, The provides strategic intelligence on:

  • Strengths and weaknesses
  • Category and country opportunities for growth
  • Challenges and threats from current competition and future prospects
  • Global and regional market positions

Research you can trust:

Euromonitor International's company profile reports are written by our Consumer Health research team, a dedicated group of analysts that knows the industry inside and out. Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.

Executive summary
Procter & Gamble maintains its place in the top 10 in 2022
North America and Western Europe are key regions for Procter & Gamble
OTC remains P&G’s leading category and the US remains the largest market
OTC, VDS and brand momentum drive growth in 2022
US remains a key source of growth for P&G over the forecast period
Top company rankings anticipated to remain unchanged over the forecast period
P&G’s share increased slightly, with mixed performance from competitors
P&G experiences significant overlap with Haleon
P&G benefits from strong positioning within CCAs
Vicks continues to build strong presence across key markets
North America and Western Europe key dietary supplements markets
Non-herbal/traditional dietary supplements lead P&G’s portfolio
Majority of growth in the future to come from the US and France
P&G ranks fourth globally in cough, cold and allergy remedies
Vicks remains dominant due to the resurgence of colds and flus
CCAs and VDS to support portfolio growth over the forecast period
Key findings
Projected company sales: FAQs (1/2)
Projected company sales: FAQs (2/2)

Consumer Health

It is the aggregation of OTC, Vitamins and Dietary Supplements (VDS), Sports Nutrition, and Weight Management and Wellbeing

See All of Our Definitions

Why buy this report:

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions


If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!